BioScience Health Innovations, Inc.
Close on Oct 16, 2026
- Market cap
- $79.22M
- P/E (TTM)
- –
- Dividend yield
- –
About BioScience Health Innovations
Services-Computer Processing & Data Preparation, SIC 7374
BioScience Health Innovations Inc., operating through its wholly owned subsidiary Best 365 Labs, Inc., is a health and wellness enterprise focused on mitochondrial health science, metabolic care, and advanced peptide delivery. The company develops and markets clinically tested natural products designed to support immune health and combat bacteria and viruses. Its core technology is the patent-pending Mineral Oxide Delivery System (MODS Max™) process, which enhances nutrient and peptide bioavailability across oral, sublingual, nasal, and topical formats. Offerings include formulations for hormonal optimization, such as its sublingual testosterone product NHTO/TPrime365, and NAD+ cellular health products. The company distributes its offerings directly to consumers via digital storefronts and through wholesale accounts and healthcare pharmacy partners.
The company conducts its corporate, administrative, order fulfillment, and logistics operations from a leased facility located at 14857 South Concord Park Drive in Bluffdale, Utah. Its activities and commercial reach span across the United States.
Summary of the business section of BioScience Health Innovations's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BioScience Health Innovations, Inc.
- Founded
- 2019
- Headquarters
- Bluffdale, UT
- Address
- 14857 South Concord Park Drive 84065
- Phone
- (801) 949-0791
- Industry
- Services-Computer Processing & Data Preparation
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Mac Accounting Group & CPAs, LLP, Midvale, Utah
Stock & identifiers
- Ticker
- BHIC
- Exchange
- OTC
- IPO date
- Jun 17, 2021
- Shares outstanding
- 12M, Aug 6, 2026
- Public float
- $43.92M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-4 reverse, Oct 27, 2025; 1-for-4 reverse, Sep 26, 2025
- SEC CIK
- 1784440
- EIN
- 98-1498782
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
BioScience Health Innovations's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 13, 2025 | Name change | Name changed from Nowtransit Inc to BioScience Health Innovations, Inc. |
| Jun 25, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 22, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 16, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |